Oppenheimer analyst Steven Lichtman lowered the price target on Medtronic, Inc. (NYSE: MDT) to $106.00 (from $115.00) while maintaining a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE